Claim Details
View detailed information about this claim and its related sources.
Claim Information
Complete details about this extracted claim.
- Claim Text
-
Whether we're developing an oral drug or an intravenous drug, an antibody or a small molecule, we want to use whatever modality we believe is best to interfere or interact with the underlying biology of disease, guided by that causal human biology.
- Simplified Text
-
Bristol Myers Squibb uses best modality to interact with disease biology guided by causal human biology
- Confidence Score
- 0.500
- Claim Maker
- K. Rhodes
- Context Type
- Website Article
- Context Details
-
{ "date": null } - Subject Tags
- UUID
- 9fc8a1b2-e5aa-4880-9488-477c3e12ff37
- Vector Index
- ✗ No vector
- Created
- September 2, 2025 at 7:15 PM (1 week ago)
- Last Updated
- September 2, 2025 at 7:15 PM (1 week ago)
Original Sources for this Claim (1)
All source submissions that originally contained this claim.
37
claims
🔥
1 week ago
https://www.bms.com/life-and-science/science/renaissance-neuroscience-research-development.html?cid=d_3267515&dclid=CN-sjNPAsI8DFazArQAd_vguSA&gad_source=7
Bristol Myers Squibb is accelerating neuroscience R&D using breakthroughs in human biology, biomarkers, and computational science to improve outcomes for patients with neurological conditions. The company is exploring new approaches to slow disease progression and alleviate symptoms.
Similar Claims (0)
Other claims identified as semantically similar to this one.
No similar claims found
This claim appears to be unique in the system.